EichorEICHOR
Location: Stanford Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Stanford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
NA · Board of Trustees of the Leland Stanford Junior University · Stanford University · NCT06251323Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Arkansas Children's Hospital Research Institute · NCT03827694ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Stanford University Medical Center · Edwards Lifesciences · NCT05172973A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Takeda · NCT06747351Use of Artificial Intelligence to Assess Trainee Communication Compared to Human Assessment
NA · Stanford University · NCT07107880Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2 · Darcy Krueger · NCT05104983A Registry for People With T-cell Lymphoma
Phase N/A · Stanford University Medical Center (Data collection only) · Memorial Sloan Kettering Cancer Center · NCT05978141A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · Harmony Biosciences Management, Inc. · NCT07500090GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
Phase 1 · Lucile Packard Children's Hospital (LPCH) · Stanford University · NCT04196413A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NA · Stanford University · Washington University School of Medicine · NCT05991453Stratified Pharmacological Approaches for Regulating Circuit-Level Effects
Phase 2 · Stanford University · NCT07022405A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Phase 1/Phase 2 · Stanford University · TORL Biotherapeutics, LLC · NCT07439653Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296CHIME: Comparing Health Interventions for Maternal Equity
NA · Stanford University · NCT06724172A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · Relay Therapeutics, Inc. · NCT06789913Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · Stanford University · Ashvattha Therapeutics, Inc. · NCT05395624Extended-release Sodium Oxybate in Children
Phase 2 · Stanford University · NCT06809803Low Sodium Oxybate in Patients With Idiopathic Hypersomnia
Phase 4 · Mayo Clinic · NCT05837091Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Phase N/A · Stanford University · InSightec · NCT05386615A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Phase 2 · Stanford University (Data Collection Only) · Memorial Sloan Kettering Cancer Center · NCT06594991A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Oncology Group · NCT06368817Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Phase 1/Phase 2 · Teclison Ltd. · NCT02174549A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Phase N/A · Stanford University School of Medicine · Stanford University · NCT00230308Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
Phase 2 · Stanford University · NCT06592599Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain
Phase 2/Phase 3 · Stanford University · NCT06185816A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Phase 1 · Peel Therapeutics Inc · NCT05329103The Dynamics of Human Atrial Fibrillation
Phase N/A · Stanford University · Stanford University · NCT05366361
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.